At a glance
ClinicalIndex Comparison RecordN/ACompleted· 851 enrolled
Drug / intervention
Cohortother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Open Label, Observational, Non-interventional Study for the Evaluation of Remission Rates in Patients With MDD Under Treatment With Various Anti-depressives
In Brief
An observational study evaluating Cohort for Major Depressive Disorder. Completed, enrolled 851 participants across 3 sites.
Detailed Summary
Tools known as 'depression scales 'are widely used as assessments to evaluate a patient's response to treatment. The purpose of this study is the evaluation of the remission rates for patients with MDD. The evaluation will involve the use of HAM-D 17, and HAM-D 7 questionnaires and the comparison of those questionnaires.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMajor Depressive Disorder
CountriesGreece
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMay 2008
First PostedOct 2008
Primary CompletionDec 2009
TodayJul 2026
First PostedOct 9, 2008
Enrollment StartMay 1, 2008
Primary CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 17.7 years ago
Interventions
Cohortother
Cohort (Patients diagnosed with MDD who are either changing treatment or have never received treatment).